Ray Co., Ltd. (KOSDAQ:228670)
5,260.00
+240.00 (4.78%)
Apr 1, 2026, 3:30 PM KST
Ray Co., Ltd. Market Cap
Ray Co., Ltd. has a market cap or net worth of 82.07 billion as of April 1, 2026. Its market cap has decreased by -32.95% in one year.
Market Cap
82.07B
Enterprise Value
108.48B
Revenue
111.32B
Ranking
n/a
PE Ratio
26.22
Stock Price
5,260.00
Market Cap Chart
Since August 8, 2019, Ray Co., Ltd.'s market cap has decreased from 164.67B to 82.07B, a decrease of -50.16%. That is a compound annual growth rate of -9.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 1, 2026 | 82.07B | -22.30% |
| Dec 30, 2025 | 105.63B | 16.99% |
| Dec 30, 2024 | 90.29B | -74.15% |
| Dec 28, 2023 | 349.24B | 7.23% |
| Dec 29, 2022 | 325.68B | -13.67% |
| Dec 30, 2021 | 377.24B | 6.38% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Aug 8, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bio Plus | 310.16B |
| DRTECH | 140.83B |
| T&R Biofab | 130.10B |
| Osang Healthcare Co.,Ltd | 122.11B |
| P&S Robotics | 102.33B |
| LabGenomics | 97.77B |
| Sugentech | 71.33B |
| Gencurix | 60.80B |